¼¼°èÀÇ HTS(High Throughput Screening) ½ÃÀå, ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦°øº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ¿¹Ãø(2025-2034³â)
High Throughput Screening Market Size, Share, Trends, Industry Analysis Report: By Offerings (Consumables, Instruments, Services, Software), By Technology, By Application, By End User, and By Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1762373
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 129 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,928,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,323,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,718,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, HTS ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 939¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

HTS(High Throughput Screening) ½ÃÀåÀº ´Ü½Ã°£¿¡ ´Ù¼öÀÇ È­ÇÕ¹°ÀÇ »ý¹°ÇÐÀû ¶Ç´Â »ýÈ­ÇÐÀû Ȱ¼ºÀ» ½Å¼ÓÇÏ°Ô Æò°¡Çϱâ À§ÇØ »ç¿ëµÇ´Â ÀÚµ¿È­ ±â¹ýÀÔ´Ï´Ù. HTS ½ÃÀåÀÇ ¼ºÀåÀº Ãʱ⠴ܰèÀÇ ½Å¾à °³¹ß ¼­ºñ½º ¹× ÇÁ·Î¼¼½º °¡¼ÓÈ­¿¡ ÁßÁ¡À» µÎ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ ±â¼úÀº ¿¬±¸ÀÚµéÀÌ Æ¯Á¤ »ýü ºÐÀÚ °æ·Î¸¦ Á¶ÀýÇϴ Ȱ¼º È­ÇÕ¹°, Ç×ü ¹× À¯ÀüÀÚ¸¦ ½Å¼ÓÇÏ°Ô ½Äº°ÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© Ç¥Àû °ËÁõ ¹× ¸®µå ½Äº°À» °£¼ÒÈ­ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¼Óµµ, Á¤È®¼º, È®À强 ¶§¹®¿¡ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÏÀ̽º·çDz ¹æ½Ä¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸é¼­ ÀǾàǰ °³¹ß »ýŰè Àü¹ÝÀÇ ¿¬±¸ ¿öÅ©Ç÷ο찡 ÀçÆíµÇ°í ÀÖ½À´Ï´Ù.

HTS ½ÃÀå ¼ö¿ä´Â ½ºÅ©¸®´× Ç÷§Æû¿¡ ÀΰøÁö´É°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀ¸·Î ÀÎÇØ Áõ°¡ÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ½ºÅ©¸®´× µ¥ÀÌÅÍÀÇ ¿¹Ãø·ÂÀ» Çâ»ó½ÃÄÑ Ãß°¡ °³¹ßÀ» À§ÇÑ Èĺ¸ ºÐÀÚ¸¦ º¸´Ù Á¤È®ÇÏ°Ô ¼±ÅÃÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¿¬±¸ÀÚµéÀº °í±Þ µ¥ÀÌÅÍ ºÐ¼®À» Ȱ¿ëÇÏ¿© º¹ÀâÇÑ µ¥ÀÌÅÍ ¼¼Æ®¸¦ º¸´Ù Á¤È®ÇÏ°Ô ÇØ¼®Çϰí, °¡Ä¡ Àִ Ÿ°ÙÀÇ ¿ì¼±¼øÀ§¸¦ Á¤Çϰí, À§¾ç¼º ºñÀ²À» ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ AI¿Í HTSÀÇ À¶ÇÕÀº ÀüÅëÀûÀÎ ÀǾàǰ ½ºÅ©¸®´×À» º¸´Ù Áö´ÉÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ÇÁ·Î¼¼½º·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ±× °á°ú, HTS´Â ´Ü¼øÇÑ ÀÚµ¿È­¸¦ ³Ñ¾î µ¥ÀÌÅÍ ±â¹Ý Â÷¼¼´ë ÀǾàǰ ¿¬±¸ Àü·«ÀÇ ÇÙ½ÉÀ¸·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù.

HTS ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼Ò¸ðǰ ºÎ¹®Àº ½ºÅ©¸®´× ¿öÅ©Ç÷ο쿡 ÇʼöÀûÀÎ HTS ½Ã¾à ¹× ºÐ¼® ŰƮÀÇ ±¤¹üÀ§ÇÑ »ç¿ëÀ¸·Î ÀÎÇØ 2024³â HTS ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¿ëµµº°·Î´Â ½Å¾à°³¹ß ºÎ¹®ÀÌ 2024³â HTS ½ÃÀåÀ» ÁÖµµÇßÀ¸¸ç, ½Å¾à°³¹ßÀ» À§ÇÑ Á¦¾à ¹× »ý¸í°øÇÐ ¿¬±¸°³¹ß Ȱµ¿ÀÇ È°¼ºÈ­°¡ À̸¦ °ßÀÎÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÏ¹Ì°¡ 2024³â HTS ½ÃÀå¿¡¼­ °¡Àå ³ôÀº ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÌ´Â ¾Ï ¹× CVD¿Í °°Àº ¸¸¼ºÁúȯ Ä¡·áÁ¦¸¦ Ÿ°ÙÀ¸·Î ÇÏ´Â Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷µéÀÇ »ó´çÇÑ R&D ÅõÀÚ¿¡ ±âÀÎÇÕ´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ HTS ½ÃÀåÀº Àü¹® ÀǾàǰ °³¹ß ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ´Ù¾çÇÑ È¯ÀÚ Ç®¿¡ ÈûÀÔ¾î °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÁÖ¿ä ¼¼°è ½ÃÀå ÁøÃâ ±â¾÷ : Agilent Technologies, Inc., Aurora Biomed Inc., Axxam S.p.A., Biomat Srl, Bio-Rad Laboratories, Inc., BMG Labtech GmbH, Brand GmbH+Co KG, Charles River Laboratories, Corning Incorporated, Creative Biolabs, Crown Bioscience, Danaher Corporation, DIANA Biotechnologies, A.S., Eppendorf SE, Eurofins Scientific, Gilson Incorporated, Greiner AG, Hamilton Company, HighRes Biosolutions, Lonza, Merck KGaA, Mettler-Toledo International Inc., Porvair Plc, Revvity, Inc., Sartorius AG, Sygnature Discovery Limited, Tecan Group Ltd., Thermo Fisher Scientific Inc., Waters Corporation.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°è HTS(High Throughput Screening) ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ HTS(High Throughput Screening) ½ÃÀå : Á¦°øº°

Á¦6Àå ¼¼°èÀÇ HTS(High Throughput Screening) ½ÃÀå : ±â¼úº°

Á¦7Àå ¼¼°èÀÇ HTS(High Throughput Screening) ½ÃÀå : ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ HTS(High Throughput Screening) ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°èÀÇ HTS(High Throughput Screening) ½ÃÀå : Áö¿ªº°

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The high throughput screening market size is expected to reach USD 93.92 billion by 2034, according to a new study by Polaris Market Research. The report "High Throughput Screening Market Share, Size, Trends, Industry Analysis Report: By Offerings (Consumables, Instruments, Services, Software), Technology, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

High throughput screening (HTS) is an automated method used to rapidly evaluate the biological or biochemical activity of a large number of compounds in a short time. The high throughput screening market growth is increasing due to the emphasis on accelerating early-stage drug discovery services and processes. This technology enables researchers to quickly identify active compounds, antibodies, or genes that modulate a particular biomolecular pathway, thereby streamlining target validation and lead identification. HTS systems are being widely adopted for their speed, precision, and scalability as pharmaceutical and biotech companies seek to enhance research efficiency and reduce development timelines. This growing reliance on high-throughput methodologies is reshaping research workflows across the drug development ecosystem.

The HTS market demand is on the rise due to the integration of artificial intelligence and machine learning into screening platforms. These technologies are improving the predictive power of screening data, enabling more accurate selection of candidate molecules for further development. Researchers can better interpret complex datasets, prioritize high-value targets, and reduce the rate of false positives by leveraging advanced data analytics. This fusion of AI with HTS is transforming traditional drug screening into a more intelligent and cost-effective process. As a result, HTS is evolving beyond simple automation toward becoming a cornerstone of data-driven, next-generation pharmaceutical research strategies.

High Throughput Screening Market Report Highlights

In terms of offering, the consumables segment accounted for the largest high throughput screening market share in 2024, owing to extensive utilization of HTS reagents and assay kits critical for screening workflows.

Based on application, the drug discovery segment led the high throughput screening market in 2024, fueled by intensified pharmaceutical and biotech R&D activities for novel drug development.

North America captured the highest high throughput screening market revenue share in 2024, attributed to substantial R&D investments by pharma-biotech firms targeting chronic disease therapeutics like cancer and CVDs.

The Asia Pacific high throughput screening market is anticipated to grow at the fastest rate, supported by its diverse patient pool driving demand for specialized drug development solutions.

A few global key market players include Agilent Technologies, Inc., Aurora Biomed Inc., Axxam S.p.A., Biomat Srl, Bio-Rad Laboratories, Inc., BMG Labtech GmbH, Brand GmbH+Co KG, Charles River Laboratories, Corning Incorporated, Creative Biolabs, Crown Bioscience, Danaher Corporation, DIANA Biotechnologies, A.S., Eppendorf SE, Eurofins Scientific, Gilson Incorporated, Greiner AG, Hamilton Company, HighRes Biosolutions, Lonza, Merck KGaA, Mettler-Toledo International Inc., Porvair Plc, Revvity, Inc., Sartorius AG, Sygnature Discovery Limited, Tecan Group Ltd., Thermo Fisher Scientific Inc., Waters Corporation.

Polaris Market Research has segmented the high throughput screening market report on the basis of offerings, technology, application, end user, and region:

By Offering Outlook (Revenue, USD Billion, 2020-2034)

Consumables

Reagents & Assay Kits

Laboratory Consumables

Instruments

Liquid Handling Systems

Detection Systems

Imaging Systems

Others

Services

Software

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Cell-based Assays

2D Cell Culture

3D Cell Culture

Scaffold-based Technology

Scaffold-free Technology

Reporter-based Assays

Perfusion Cell Culture

Lab-on-a-Chip Technology (LOC)

Label-free Technology

By Application Outlook (Revenue, USD Billion, 2020-2034)

Drug Discovery

Biochemical Screening

Life Sciences Research

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Contract Research Organizations (CROs)

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global High Throughput Screening Market Insights

5. Global High Throughput Screening Market, by Offerings

6. Global High Throughput Screening Market, by Technology

7. Global High Throughput Screening Market, by Application

8. Global High Throughput Screening Market, by End User

9. Global High Throughput Screening Market, by Geography

10. Competitive Landscape

11. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â